AMICUS THERAPEUTICS, INC. — Director's Dealing 2015

May 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-05-08

Reporting Person: Barth Jay (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-08	Common stock	M	25000	—	Acquired	25000	Direct
2015-05-08	Common stock	F	9313	$10.80	Disposed	15687	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-08	Restricted stock units	$	M	25000	Disposed		Common Stock (25000)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.